ROYALTY AGREEMENT BETWEEN BIOVEST INTERNATIONAL, INC. AND ACCENTIA BIOPHARMACEUTICALS, INC.Royalty Agreement • November 14th, 2006 • Biovest International Inc • Pharmaceutical preparations • Delaware
This Royalty Agreement (this “Agreement”) effective as of October 31, 2006, by and between BIOVEST INTERNATIONAL, INC., a Delaware corporation (“Biovest”) and ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation, (“Accentia”) (collectively the “Parties”).
Biolender Purchase AgreementPurchase Agreement • November 14th, 2006 • Biovest International Inc • Pharmaceutical preparations • Delaware
This Purchase Agreement (this “Agreement”) is dated as of October 31, 2006, is made by and between Biovest International, Inc., a Delaware corporation (“Biovest”) and Accentia Biopharmaceuticals, Inc. a Florida Corporation (“Accentia”).
TERMINATION AGREEMENT BETWEEN BIOVEST INTERNATIONAL, INC. AND ACCENTIA BIOPHARMACEUTICALS, INC.Termination Agreement • November 14th, 2006 • Biovest International Inc • Pharmaceutical preparations • Delaware
This Termination Agreement (this “Termination Agreement”) effective as of October 31, 2006, by and between BIOVEST INTERNATIONAL, INC., a Delaware corporation (“BIOVEST”) and ACCENTIA BIOPHARMACEUTICALS, INC., f/k/a Accentia, Inc., a Florida corporation, (“ACCENTIA”) (collectively the “Parties”).
CONSENTConsent • November 14th, 2006 • Biovest International Inc • Pharmaceutical preparations
This Consent (the “Consent”), dated as of October 31, 2006, is entered into by and between Biovest International, Inc., a Delaware corporation (“Biovest”), Biolender, LLC, a Delaware limited liability company (“Biolender”), AutovaxID, Inc., a Florida corporation (“AutovaxID” and, together with Biovest and Biolender, the “Biovest Credit Parties” and each, a “Biovest Credit Party”) and Laurus Master Fund, Ltd., a Cayman Islands company (“Laurus”), in connection with (i) that certain Note and Warrant Purchase Agreement (as amended, modified or supplemented, the “Purchase Agreement” and, together with the Related Agreements and Security Documents, each as defined therein, the “Biovest Funding Documents”), dated as of March 31, 2006, by and between Biovest and Laurus, (ii) that certain Securities Purchase Agreement, dated as of April 29, 2005, by and between Accentia Biopharmaceuticals, Inc., a Florida corporation (“Accentia”) and Laurus (as amended, modified or supplemented, the “Accentia
